Treatment options and outcome for renal cell tumors in the transplanted kidney

International Journal of Artificial Organs

Volumn 31, Issue 10, 2008, Pages 867-874

  Diller, Ricarda ^a   Senninger, N ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Kidney transplant; Renal cell carcinoma; Renal transplant; Renal tumor

Indexed keywords

CELLS; CYTOLOGY; DIAGNOSIS;

'CURRENT; CRYO ABLATIONS; KIDNEY TRANSPLANTS; RADIOFREQUENCY ABLATION; RENAL CELL; RENAL CELL CARCINOMA; RENAL TRANSPLANTS; RENAL TUMORS; TRANSPLANTED KIDNEY; TUMOR THERAPY;

TUMORS;

MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;

CRYOABLATION; DIALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CARCINOMA; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; NEPHRECTOMY; OUTCOME ASSESSMENT; RADIOFREQUENCY ABLATION; REVIEW; SURGICAL TECHNIQUE;

EID: 59549097950     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880803101002     Document Type: Review

References (81)

1. Linehan WM, Walther MM, Zbar B. The genetic basis of cancer of the kidney. J Urol 2003; 170: 2163-72.
2. Diller R, Gruber A, Wolters H, Senninger N, Spiegel HU. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation. Transplant Proc 2005; 37: 2089-92.
3. Neuzillet Y, Lay F, Luccioni A, Daniel L, Berland Y, Coulange C, Lechevallier E. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 2005; 103: 251-7.
4. Shum CF, Lau KO, Sy JL, Cheng WS. Urological complications in renal transplantation. Singapore Med J 2006; 47: 388-91.
5. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther 2000; 7: 147-55.
6. Schwarz A, Vatandaslar S, Merkel S, Haller H. Renal cell carcinoma in transplant recipients with acquired cystic kidney disease. Clin J Am Soc Nephrol 2007; 2: 750-6.
7. Wunderlich H, Wilhelm S, Reichelt O, Zermann DH, Börner R, Schubert J. Renal cell carcinoma in renal graft recipients and donors: incidence and consequence. Urol Int 2001; 67: 24-7.
8. Sheil AG. Donor-derived malignancy in organ transplant recipients. Transplant Proc 2001; 33: 1827-9.
9. Wunderlich H, Junker K, Kosmehl H, Wilhelm S, Reichelt O, Schubert J. Malignant behavior of incidentally found small renal cell carcinomas in renal graft donors and recipients. Transplant Proc 2002; 34: 2224.
10. Manikandan R, Srinivasan V, Rané A. Which is the real gold standard for small-volume renal tumors? Radical nephrectomy versus nephron sparing surgery. J Endourol 2004; 18: 39-44.
11. Moudouni SM, Tligui M, Doublet JD, Haab F, Gattegno B, Thibault P. Nephron-sparing surgery for de novo renal cell carcinoma in allograft kidneys. Transplantation 2005; 80: 865-7.
12. Penn I. Primary kidney tumors before and after renal transplantation. Transplantation 1995; 59: 480-5.
13. Walton TJ, McCulloch TA, Bishop MC. Aggressive renal cell carcinoma in a 27-year-old kidney transplant. Nephrol Dial Transplant 2005; 20: 1018-9.
14. Barama A, St-Louis G, Nicolet V, Hadjeres R, Daloze P. Renal cell carcinoma in kidney allografts: a case series from a single center. Am J Transplant 2005; 5: 3015-8.
15. Kunisch-Hoppe M, Hoppe M, Bohle RM, Rauber K, Weimar B, Friemann S, Stahl U, Rau WS. Metastatic rcc arising in a transplant kidney. Eur Radiol 1998; 8: 1441-3.
16. Lotan D, Laufer J. Metastatic renal carcinoma in a pediatric recipient of an adult cadaveric donor kidney. Am J Kidney Dis 1995; 26: 960-2.
17. Mundel TM, Schaefer KL, Colombo-Benkmann M, Dietl KH, Diallo-Danebrock R, Senninger N. Nephron-sparing surgery of a low grade renal cell carcinoma in a renal allograft 12 years after transplantation. Cancer Biol Ther 2007; 6: 1700-3.
18. Pfister C, Etienne I, Gobet F, Godin M, Grise P. Adenocarcinoma on renal allofraft as a complication at 5 years. Transplantation 1999; 68: 1608.
19. Roupret M, Peraldi MN, Thaunat O, Chrétien Y, Thiounn N, Dufour B, Kreis H, Méjean A. Renal cell carcinoma of the grafted kidney: how to improve screening and graft tracking. Transplantation 2003; 77: 146-8.
20. Schostak M, Heicappell R, Saurer T Goessl C, Krause H, Hoyer J, Miller K. Renal cell carcinoma in a kidney transplant: allogeneic genome in the tumor justifies organ-preserving surgery. Transplant Proc 2002; 34: 2231-2.
21. Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasm: further observation on growth. Radiology 1995; 197: 589-97.
22. Heinz-Peer G, Helbich T, Nottling B, Klauser R, Mühlbacher F, Hübsch P. Renal cell carcinoma in an allograft transplant. Transplantation 1994; 57: 475-8.
23. Heinz-Peer G, Helbich T, Barnas U, Mayer G, Mühlbacher F, Mostbeck GH. Renal cell carcinoma of donor origin in two kidney transplants from a single donor. Transplantation 1995; 59: 912-3.
24. Tydén G, Wernersson A, Sandberg J, Berg U. Development of renal cell carcinoma in living donor kidney grafts. Transplantation 2000; 70: 1650-6.
25. Dubernard JM, Martin X, Neyra P, Touraine JL, Malik MC, Traeger J. Successive appearance of carcinoma, tuberculosis and nephrolithiasis in a renal allograft. J Urol 1980; 124: 540-2.
26. Gunji Y, Sakamoto K, Yamada K, Hamaguchi K, Kashiwabara H, Hori S, Shimada H, Suzuki T, Ochiai T. Successful surgical treatment of renal cell carcinoma in a transplanted kidney from a cadaveric donor: report of a case. Surg Today 2001; 31: 374-7.
27. Pope JC, Koch MO, Bluth RF. Renal cell carcinoma in patients with end-stage renal disease: a comparison of clinical significance in patients receiving hemodialysis and those with renal transplants. Urology 1994; 44: 497-501.
28. Siebels M, Theodorakis J, Liedl B, Schneede P, Hofstetter A. Large de novo renal cell carcinoma in a 10-years old transplant kidney. Transplantation 2000; 269: 677-9.
29. Tunner WS, Goldsmith EI, Whitsell JC 2nd. Human homotransplantations of normal and neoplastic tissue from the same organ. J Urol 1971; 195: 18-20.
30. Buell JF, Gross T, Alloway RR, Trofe J, Woodle ES. Central nervous system tumors in donors: misdiagnosis carries a high morbidity and mortality. Transplant Proc 2005; 37: 583-4.
31. Kausman JY, Somers GR, Francis DM, Jones CL. Association of renal adenocarcinoma and BK virus and BK nephropathy post transplantation. Pediatr Nephrol 2004; 19: 459-62.
32. Kooistra MP, Vos PF, de Graaf PW, Gmelig-Meyling FH, de Graeff A, Lock TM, de Gast GC, Vroom TM, Hené RJ. Metastatic renal cell carcinoma developing in two recipients of renal grafts derived from the same donor. Nephrol Dial Transplant 1995; 10: 1772-4.
33. Narayanan M, Szymanski J, Slavcheva E, Rao A, Kelly A, Jones K, Faffers G. BK Virus asssociated renal cell carcinoma: case presentation with optimized pcr and other diagnostic tests. Am J Transplant 2007; 7: 1666-71.
34. Russo P. Open partial nephrectomy: an essential operation with an expanding role. Curr Opin Urol 2007; 17: 309-15.
35. Kwon EO, Carver BS, Snyder ME, Russo P. Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int 2004; 99: 286-9.
36. Sutherland SE, Resnick MI, Maclennan GT, Goldman HB. Does the size of the surgical margin in partial nephrectomy for renal cancer really matter? J Urol 2002; 167: 61-4.
37. Richstone L, Scherr DS, Reuter VL Snyder ME, Rabbani F, Kattan MW, Russo P. Multifocal renal cortical tumors: frequency associated clinicopathologic features, and impact on survival. J Urol 2004; 171: 615-20.
38. Fergany AF, Hafez KS Novick AC. Long-term results of nephron sparing surgery for localized for renal cell carcinoma: 10 year follow up. J Urol 2000; 163: 442-5.
39. Schlomer B, Figenshau RS, Yan Y, Venkatesh R, Bhayani SB. Pathological features of renal neoplasms classified by size and symptomatology. J Urol 2006; 176: 1317-20.
40. Claudon M, Panescu V, Le Chaffotec L, Hubert J, Martin-Bertaux A, Lefevre F, Andre JH, Kessler M. Primary adenocarcinoma of the renal transplant. Nephrol Dial Transplant 1998; 13: 2667-70.
41. Agrawal R, Picken M, Kinzler GJ, Hatch D, Moel DI. Renal cell carcinoma developing in the pediatric recipient of an adult cadaveric donor kidney. Pediatr Nephrol 1994; 8: 595-7.
42. Kmetec A, Kaplan-Pavlovcic S, Ferluga D. Renal cell carcinoma in nonfunctioning transplanted kidney. Am J Nephrol 2001; 21: 256-8.
43. Ianhez LE, Lucon M, Nahas WC, Sabbaga W, Saldanha LB, Lucon AM, Srougi M. Renal cell carcinoma in renal transplant patients. Urology 2007; 69: 462-4.
44. Scott MH, Sells RA. Primary adenocarcinoma in a transplanted cadaveric kidney. Transplantation 1988; 46: 157-8.
45. Williams JC, Merguerian PA, Schned AR, Morrison PM. Acquired renal cystic disease and renal cell carcinoma in an allograft kidney. J Urol 1995; 153: 395-6.
46. DeLong MJ, Schmitt D, Scott KM, Ramakumar S, Lien YH. Multicentric papillary renal carcinoma in renal allograft. Am J Kidney Dis 2003; 42: 381-4.
47. Roy C, El Ghali S, Buy X, Lindner V, Gangi A. Papillary renal cell carcinoma in allograft kidney. Eur Radiol 2005; 15: 661-5.
48. Feldman JD, Jacobs SC. Late development of renal carcinoma in allograft kidney. J Urol 1992; 148: 395-7.
49. Krishnamurthi V, Novick AC. Nephron-sparing surgery in a renal allograft. Urology 1997; 50: 132-4.
50. Lamb GWA, Baxter GM, Rodger RSC, Aitchison M. Partial nephrectomy used to treat renal cell carcinoma arising in a live donor transplant kidney. Urol Res 2004; 32: 89-92.
51. Goeman L, Joniau S, Oyen R, van Poppel H. Percutaneous ultrasound-guided radiofrequency ablation of recurrent renal cell carcinoma in renal allograft after partial nephrectomy. Urology 2006; 67: 199e.
52. Lledo-Garcia E, Duran-Merino R, Moralejo-Gerate M, Mohzo JI, Hernandez-Fernandez. Subcapsular nephron-sparing surgical approach for small renal graft tumor: A case report. Transplant Proc 2007; 39: 301-4.
53. Merkel FK, Miller JL, Hibblen JF, Owens JC. Partial nephrectomy with in situ perfusion preservation for renal cell carcinoma in a long established renal transplant. Transplant Proc 1998; 30: 2295-7.
54. Cox A, Nguan CY, Luke PP. Partial nephrectomy for renal cell carcinoma in long-term renal allografts: operative and postoperative considerations. Can J Urol 2005; 12: 2887-90.
55. Thomalla JV. Renal cell carcinoma in a renal allograft successful treatment with 5 year follow-up. Clin Med Res 2004; 2: 151-3.
56. Cherif M Rouache L, Tapon E, Pfister C. Usefulness of inline radiofrequency device in renal allograft preserving surgery. Transplantation 2007; 83: 522-3.
57. Kim JY, Ruckle HC Ramin SA. Partial nephrectomy for renal cell carcinoma in an allograft kidney 15 years after transplantation. J Urol 2001; 165: 1205.
58. Ribal MJ, Rodriguez F, Musquera M, Segarra J, Guirado L, Villavicencio H, Alcaraz A. Nephron sparing surgery for renal tumor: a choice of treatment in an allograft kidney. Transplant Proc 2006; 38: 1359-62.
59. Neipp M, Schwarz A, Pertschy S, Klempnauer J, Becker T. Accidental transplantation of a kidney with a cystic renal cell carcinoma following living donation: management and 1yr follow-up. Clin Transplant 2006; 20: 147-50.
60. Hruby GW, Fine JK, Landman J. Ultrasound guided percutaneous ablation of a renal mass in a renal allograft. Urology 2006; 891: e5-e6.
61. Shingleton WB, Sewell PE. Percutaneous cryoablation of renal cell carcinoma in a transplanted kidney. BJU Int 2002; 90: 137-8.
62. Aron M, Hegarty NJ, Remer E, O'Malley C, Goldfarb D, Kaouk JH. Percutaneous treatment of radiofrequeny ablation of tumor in transplanted kidney. Urology 2007 69; 778. e5-e7.
63. Baughman SM, Sexton WJ, Glanton CW, Dalrymple NC, Bishoff JT. Computerized tomography guided radio frequency ablation of a renal cell carcinoma within a renal allograft. J Urol 2004; 172: 1262-3.
64. Charboneau JW, O'Loughlin MT, Milliner DS, Engen DE. Sonographically guided percutaneous radio frequency ablation of a renal cell carcinoma in a transplanted kidney. J Ultrasound Med 2002; 21: 1299-302.
65. Buell JF, Hanaway MJ, Thomas M, Munda R, Alloway RR, First MR, Woodle ES. Donor kidneys with small renal cell cancers: can they be transplanted? Transplant Proc 2005; 37: 581-2.
66. Ghafari A. Transplantation of a kidney with a renal cell carcinoma after living donation: a case report. Transplant Proc 2007; 39: 1660-1.
67. Mitsuhata N, Ito S. Donor kidneys with small renal cell cancer or low-grade lower ureteral cancer can be transplanted. Transplantation 2007; 83: 1522-3.
68. Kunikata S, Imanishi M, Akiyama T, Kunta T. Comparative study of renal carcinomas in renal transplant, dialysis, and general (nongrafted and nonuremic) patients. Transplant Proc 2000; 32: 1986-7.
69. Khan T, Chakrabarty A, Baborie A. Renal cell carcinoma in allograft kidney - a case report with unusual findings at autopsy. Int J Urol 2007; 14: 652-4.
70. Lawrence SK, van Buren DH, MacDonell RC, Delbeke D. Carcinoma in a transplanted kidney detected with MAG3 scintigraphy. J Nucl Med 1993; 34: 2185-7.
71. Lasaponara F, Catti M, Ferraris C, Volpe A, Ferrando U. Nephron sparing treatment of kidney neoplasm in transplanted kidney. Our experience. Minerva Urol Nefrol 2000; 52: 179-81.
72. Mindrup S, Rayhill, Fallon B. Renal cell carcinoma in a transplanted kidney. J Urol 2001; 165: 1990.
73. De Simone P, Antonacci V, Rosa F, Verzaro R. Nephron-sparing surgery for de novo renal cell carcinoma in a 19-year-old transplanted kidney. Transplantation 2004; 77: 478.
74. Park KI, Inoue Y, Arai T Yoshiki T, Tomoyoshi T. Enucleation of renal cell carcinoma in an allograft kidney 21 years after transplantation. Br J Urol 1997; 80: 339-40.
75. Höppner W, Grosse K, Dreikorn K. Renal cell carcinoma in a transplanted kidney: successful organ-preserving procedure. Urol Int 1996; 56: 110-11.
76. Descotes JL, PAsquier D, Bayle F Teil E, Rambeaud JJ. Management of oncocytoma in transplanted kidney. Prog Urol 2001; 11: 91-4.
77. Amirzagar MA, Yavangi M. Nephron sparing surgery in a transplanted kidney renal cell carcinoma. Saudi J Kidney Dis Transplant 2004; 15: 494-6.
78. Hernandez Sánchez JE, Gómez Vegas A, Blásquez Izquierda J, San José Manso L, Alonso Prieto M, Pérez Romero N, Silmi Moyano A. Nephron sparing surgery for the treatment of renal carcinoma in a functioning graft: case report. Arch Exp Urol 2007; 60: 295-7.
79. Marco M, Webb NJ, Dyer PA, Mallik NS. Renal cancer in renal transplant recipients. Transplantation 2000; 70: 1552-3.
80. Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80: 883-9.
81. Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran. Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 2003; 63: 917-26.